Activation of pericytes: Recent insights into kidney fibrosis and microvascular rarefaction

Current Opinion in Rheumatology

Volumn 25, Issue 1, 2013, Pages 78-86

  Fligny, Cécile ^a   Duffield, Jeremy S ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chronic disease; fibrosis; microvasculature; pericytes

Indexed keywords

CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; FIBROBLAST; FIBROGENESIS; HUMAN; KIDNEY FIBROSIS; MICROVASCULATURE; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; REVIEW;

ANIMALS; FIBROSIS; HUMANS; KIDNEY; MICE; MICROVESSELS; PERICYTES;

EID: 84871186965     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32835b656b     Document Type: Review

References (46)

1. Stratman AN, Davis GE. Endothelial cell-pericyte interactions stimulate base-ment membrane matrix assembly: influence on vascular tube remodeling, maturation, and stabilization. Microsc Microanal 2012; 18:68-80.
2. Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473:298-307.
3. Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell 2011; 146:873-887.
4. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97:512-523.
5. Rhodin JA. Ultrastructure of mammalian venous capillaries, venules, and small collecting veins. J Ultrastruct Res 1968; 25:452-500.
6. Crisan M, Yap S, Casteilla L, et al. Aperivascularorigin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3:301-313.
7. Díaz-Flores L, Gutiérrez R, Madrid JF, et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009; 24:909-969.
8. Stratman AN, Malotte KM, Mahan RD, et al. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood 2009; 114:5091-5101.
9. Stratman AN, Schwindt AE, Malotte KM, Davis GE. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 2010; 116:4720-4730.
10. Senger DR, Davis GE. Angiogenesis. Cold Spring Harb Perspect Biol 2011; 3:a005090.
11. Von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp Cell Res 2006; 312:623-629.
12. Humphreys BD, Lin S-L, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176:85-97.
13. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011; 21:193-215.
14. Smith SW, Chand S, Savage COS. Biology of the renal pericyte. Nephrol Dial Transplant 2012; 27:2149-2155.
15. Liu Y. Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7:684-696.
16. Murakami M. Signaling required for blood vessel maintenance: molecular basis and pathological manifestations. Int J Vasc Med 2012; 2012:293641.
17. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214:199-210.
18. Kisseleva T, Brenner DA. Antifibrogenic strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol 2011; 25:305-317.
19. Strutz F. How many differentroads mayacell walkdown in orderto becomea fibroblast? J Am Soc Nephrol 2008; 19:2246-2248.
20. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010; 21:1247-1253.
21. Kisseleva T, Brenner DA. Is it the end of the line for the EMT? Hepatology 2011; 53:1433-1435.
22. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121:468-474.
23. Quaggin SE, Kapus A. Scar wars: mapping the fate of epithelial-mesench- ymal-myofibroblast transition. Kidney Int 2011; 80:41-50.
24. Iwaisako K, Brenner DA, Kisseleva T. What'snewin liver fibrosis-The origin of myofibroblasts in liverfibrosis. J Gastroenterol Hepatol 2012; 27 (Suppl 2): 65-68.
25. Armulik A, Genové G, Mäe M, et al. Pericytes regulate the blood-brain barrier. Nature 2010; 468:557-561.
26. Göritz C, Dias DO, Tomilin N, et al. A pericyteorigin of spinal cord scartissue. Science 2011; 333:238-242.
27. Rock JR, Barkauskas CE, Cronce MJ, et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesench-ymal transition. Proc Natl Acad Sci USA 2011; 108:E1475-E1483.
28. Lin S-L, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173:1617-1627.
29. Rojas A, Chang FC, Lin SL, Duffield JS. Therole played by perivascularcells in kidney interstitial injury. Clin Nephrol 2012; 77:400-408.
30. Bielesz B, Sirin Y, Si H, et al. Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans. J Clin Invest 2010; 120:4040-4054.
31. Koesters R, Kaissling B, Lehir M, et al. Tubularoverexpression oftransforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010; 177:632-643.
32. Li L, Zepeda-Orozco D, Black R, Lin F. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 2010; 1 76:1 767-1778.
33. Blomhoff R, Wake K. Perisinusoidal stellatecellsof the liver: important roles in retinol metabolism and fibrosis. FASEB J 1991; 5:271-277.
34. Pinzani M. Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte. J Hepatol 1995; 22:700-706.
35. Fabris L, Strazzabosco M. Epithelial-mesenchymal interactions in biliary diseases. Semin Liver Dis 2011;31:11-32.
36. Kisseleva T, Cong M, Paik Y, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA 2012; 109:9448-9453.
37. Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 2012; 8:42-54.
38. Fragiadaki M, Mason RM. Epithelial-mesenchymal transition in renal fibrosis: evidenceforand against. Int J Exp Pathol 2011; 92:143-150.
39. Duffield JS, Humphreys BD. Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int 2011; 79:494-501.
40. Lin S-L, Chang F-C, Schrimpf C, et al. Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 2011; 178:911-923.
41. Mayer G. Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease. Nephrol Dial Transplant 2011; 26:1132-1137.
42. Basile DP, Friedrich JL, Spahic J, et al. Impaired endothelial proliferation and mesenchymal transition contribute to vascular rarefaction following acute kidney injury. Am J Physiol Renal Physiol 2011; 300:F721-F733.
43. Basile DP, Zeng P, Friedrich JL, et al. Low proliferative potential and impaired angiogenesis of cultured rat kidney endothelial cells [Internet]. Microcircula-tion (New York, N. Y.: 1994) 2012/doi: 10. 1111/j. 1549-8719. 2012. 00193. x.
44. Schrimpf C, Xin C, Campanholle G, et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 2012; 23:868-883.
45. Basile DP, Sutton TA. Activated pericytes and the inhibition of renal vascular stability: obstacles for kidney repair. J Am Soc Nephrol 2012; 23:767-769.
46. Long DA, Norman JT, Fine LG. Restoring the renal microvasculature to treat chronic kidney disease. Nat Rev Nephrol 2012; 8:244-250.